Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00333853 · ClinicalTrials.gov registry record · NA
Self-Monitoring of Blood Glucose Study#1: The Ability of People With Diabetes to Use OneTouch(R) Ultrasmart(tm)
A NA study of Diabetes, sponsored by LifeScan.
- Completed
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 7
- Study locations
NCT00333853 is a NA study of Diabetes that has completed, run by LifeScan. The registered enrollment target is 250 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower). The trial reports 7 study locations across 6 states.
The verdict
NCT00333853, a NA study of Diabetes, has completed, sponsored by LifeScan.
- COMPLETED
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 7
- Study locations
Study Summary
Insulin therapy requires monitoring and frequent review of glucose levels to optimize dosing. Effective presentation and data analysis are essential. We examined HbA1c changes using the OneTouch(R) UltraSmart(R) System (Test Group), an integrated glucose meter and electronic logbook, compared to established meters with paper logbooks (Control Group).
Conditions Studied
Interventions
- DEVICE OneTouch(r) UltraSmart(r)
Study Locations (7)
California
- Diabetes and Endocrine Associates - La Jolla
- Children's Hospital, Los Angeles - Los Angeles
Florida
- University of Miami Miller School of Medicine - Miami
Maryland
- University of Maryland School of Medicine - Baltimore
Massachusetts
- Joslin Diabetes Center - Boston
Missouri
- Washington University School of Medicine - St Louis
Oregon
- Radiant Research - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2003-08 |
| Est. Completion | 2005-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00333853
The ClinicalTrials.gov registry entry for NCT00333853 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (92% lower). The listed sponsor is LifeScan, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which OneTouch(r) UltraSmart(r) is the first listed.
NCT00333853 reports 7 study locations spanning 6 distinct geographic areas - top geographies include California, Florida, Maryland.
Frequently Asked Questions
What is clinical trial NCT00333853 about?
NCT00333853 is a clinical study titled "Self-Monitoring of Blood Glucose Study#1: The Ability of People With Diabetes to Use OneTouch(R) Ultrasmart(tm)". Insulin therapy requires monitoring and frequent review of glucose levels to optimize dosing. Effective presentation and data analysis are essential. We examined HbA1c changes using the OneTouch(R) UltraSmart(R) System (Test Group), an integrated glucose meter and electronic logbook, compared to est...
What is the current status of trial NCT00333853?
This trial is currently completed. It is a NA study. The enrollment target is 250 participants. The study started on 2003-08. Estimated completion is 2005-06.
What conditions does trial NCT00333853 study?
This clinical trial studies the following conditions: Diabetes.
What interventions are being tested in trial NCT00333853?
The interventions under investigation include: OneTouch(r) UltraSmart(r) (DEVICE).
Who is sponsoring clinical trial NCT00333853?
This trial is sponsored by LifeScan, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00333853 being conducted?
This trial has 7 study locations across California, Florida, Maryland, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
-
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
RECRUITING · NA
-
Bringing Advocacy Via Digital Guide to the Emergency Department (Project BADGE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.